Haptenic activity of L-phenylalanine mustard
Arai, K.; Wallace, H.W.; Blakemore, W.S.
Cancer Research 33(8): 1905-1913
1973
ISSN/ISBN: 0008-5472 PMID: 4198384 Document Number: 57874
Document emailed within 1 workday
Related Documents
Varkarakis, M.J.; Greco, J.M.; Murphy, G.P. 1973: Use of L-phenylalanine mustard (Alkeran) in canine renal allografts Journal of Medicine 4(2): 82-87Waller, M.; Moon, J.H.; Irby, R.; Toone, E.C. 1971: The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma Clinical and Experimental Immunology 8(1): 91-100
Pallante, S.L.; Fenselau, C.; Mennel, R.G.; Brundrett, R.B.; Appler, M.; Rosenshein, N.B.; Colvin, M. 1980: Quantitation by gas chromatography-chemical ionization-mass spectrometry of phenylalanine mustard in plasma of patients Cancer Research 40(7): 2268-2272
Du, D.L.; Volpe, D.A.; Grieshaber, C.K.; Murphy, M.J. 1990: Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro Cancer Research 50(13): 4038-4043
Brox, L.W.; Gowans, B.; Belch, A. 1980: L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMi 6410 human lymphoblastoid cell line Cancer Research 40(4): 1169-1172
Ducore, J.M.; McNamara, L. 1986: Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro Cancer Research 46(3): 1068-1072
Kataoka, T.; Nojima, S. 1970: Immunochemical studies of phospholipids. VI. Haptenic activity of phosphatidylinositol and the role of lecithin as an auxiliary lipid Journal of Immunology 105(2): 502-511
Schulze, W.; Horn, G. 1970: Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma Arzneimittel-Forschung 20(3): 329-335
Basu, M.; Guha, S.R. 1972: Phenylalanine hydroxylase activity in rat liver Indian Journal of Biochemistry and Biophysics 9(2): 168-170
Swanbeck, G.; Wennersten, G. 1974: Photohemolytic activity of tryptophan and phenylalanine metabolites Acta Dermato-Venereologica 54(2): 99-104
Luo, W.; Zhao, Y.-m.; Wang, Y.-x.; Xie, S.-q.; Zhao, J.; Wang, C.-j. 2007: Synthesis and antitumor activity of benzoic nitrogen mustard derivatives Yao Xue Xue Bao 42(12): 1327-1329
Grimm, U.; Knapp, A.; Tischer, W.; Schlenzka, K. 1972: Phenylalanine hydroxylase activity in hyperphenyl-alaninemia and classical phenylketonuria Acta Biologica et Medica Germanica 28(3): 549-552
Nicot, G.; Valette, J.P. 1977: Demonstration of the action of L-phenylalanine on arylesterase activity by esterase inhibitors Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 171(3): 626-630
Fan, J.Y.; Valu, K.K.; Woodgate, P.D.; Baguley, B.C.; Denny, W.A. 1997: Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity Anti-Cancer Drug Design 12(3): 181-203
Jardine, I.; Fenselau, C.; Appler, M.; Kan, M.N.; Brundrett, R.B.; Colvin, M. 1978: Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy Cancer Research 38(2): 408-415
Sireix, R.; Reynier, M.; Vaillant, J.C.; Laverdant, C.; Molinié, C.; Cristau, P. 1973: Study of activity of serum alkaline phosphatase sensitive to L-phenylalanine in human pathology Annales de Biologie Clinique 31(3): 237-242
Rey, F.; Harpey, J.P.; Leeming, R.J.; Blair, J.A.; Aicardi, J.; Rey, J. 1977: Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase Archives Francaises de Pediatrie 34(7 Suppl): CIX-CXX
Munier, R.L.; Bompeix, G.; Saindrenan, P. 1986: Inhibitory effect of various hydrazine derivatives on the activity of L-phenylalanine ammonia-lyase from Rhodotorula glutinis Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 180(3): 302-308
Pivnik, A.V.; Tonkoglaz, V.N.; Boĭko, D.V. 2006: Haptenic agranulocytosis: treatment with hemopoietic growth factors Klinicheskaia Meditsina 84(3): 55-59
Del Guercio, P.; Thobie, N.; Poirier, M.F. 1974: IgM anamnestic immune response to the haptenic determinant DNP on a thymus-independent carrier Journal of Immunology 112(1): 427-429